{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:13:41Z","timestamp":1794255221435,"version":"4.9.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Transplant-associated thrombotic microangiopathy (TA-TMA) is an important cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). The complement inhibitor eculizumab improves TA-TMA, but not all patients respond to therapy, prompting a search for additional targetable pathways of endothelial injury. TA-TMA is relatively common after HSCT and can serve as a model to study mechanisms of tissue injury in other thrombotic microangiopathies. In this work, we performed transcriptome analyses of peripheral blood mononuclear cells collected before HSCT, at onset of TA-TMA, and after resolution of TA-TMA in children with and without TA-TMA after HSCT. We observed significant upregulation of the classical, alternative, and lectin complement pathways during active TA-TMA. Essentially all upregulated genes and pathways returned to baseline expression levels at resolution of TA-TMA after eculizumab therapy, supporting the clinical practice of discontinuing complement blockade after resolution of TA-TMA. Further analysis of the global transcriptional regulatory network showed a notable interferon signature associated with TA-TMA with increased STAT1 and STAT2 signaling that resolved after complement blockade. In summary, we observed activation of multiple complement pathways in TA-TMA, in contrast to atypical hemolytic uremic syndrome (aHUS), where complement activation occurs largely via the alternative pathway. Our data also suggest a key relationship between increased interferon signaling, complement activation, and TA-TMA. We propose a model of an \u201cinterferon-complement loop\u201d that can perpetuate endothelial injury and thrombotic microangiopathy. These findings open opportunities to study novel complement blockers and combined anti-complement and anti-interferon therapies in patients with TA-TMA and other microangiopathies like aHUS and lupus-associated TMAs.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001515","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T12:03:19Z","timestamp":1585051399000},"page":"1166-1177","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Interferon-complement loop in transplant-associated thrombotic microangiopathy"],"prefix":"10.1182","volume":"4","author":[{"given":"Sonata","family":"Jodele","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Medvedovic","sequence":"first","affiliation":[{"name":"Division of Biostatistics and Bioinformatics, Department of Environmental Health, University of Cincinnati, Cincinnati, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Luebbering","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Biostatistics and Bioinformatics, Department of Environmental Health, University of Cincinnati, Cincinnati, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-9203","authenticated-orcid":false,"given":"Christopher E.","family":"Dandoy","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Laskin","sequence":"first","affiliation":[{"name":"Division of Nephrology, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"issue":"3","key":"2020032411302318100_B1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"issue":"4","key":"2020032411302318100_B2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2020032411302318100_B3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"3","key":"2020032411302318100_B4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.pcl.2013.02.007","article-title":"Advances in critical care of the pediatric hematopoietic stem cell transplant patient","volume":"60","author":"Chima","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"2020032411302318100_B5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MPH.0000000000000401","article-title":"Intensive care unit admissions among children after hematopoietic stem cell transplantation: incidence, outcome, and prognostic factors","volume":"37","author":"Fern\u00e1ndez-Garc\u00eda","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"2020032411302318100_B6","first-page":"666","article-title":"[Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review.]","volume":"37","author":"Han","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"4","key":"2020032411302318100_B7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hon.2310","article-title":"Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study","volume":"35","author":"Ye","year":"2017","journal-title":"Hematol Oncol"},{"issue":"3","key":"2020032411302318100_B8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.seminhematol.2018.04.003","article-title":"Complement in pathophysiology and treatment of transplant-associated thrombotic microangiopathies","volume":"55","author":"Jodele","year":"2018","journal-title":"Semin Hematol"},{"key":"2020032411302318100_B9","first-page":"307","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume-title":"Biol Blood Marrow Transplant","author":"Jodele","year":"2015"},{"key":"2020032411302318100_B10","article-title":"Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab [published online ahead of print 13 January 2020]","author":"Jodele","journal-title":"Blood"},{"key":"2020032411302318100_B11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.thromres.2018.01.039","article-title":"Endothelial cell functions impaired by interferon in vitro: insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy","volume":"163","author":"Jia","year":"2018","journal-title":"Thromb Res"},{"key":"2020032411302318100_B12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2017.02.011","article-title":"Interferon induced thrombotic microangiopathy (TMA): analysis and concise review","volume":"112","author":"Kundra","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"2020032411302318100_B13","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"2020032411302318100_B14","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2020032411302318100_B15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","article-title":"New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"54","author":"Jodele","year":"2016","journal-title":"Transfus Apheresis Sci"},{"issue":"4","key":"2020032411302318100_B16","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"issue":"2","key":"2020032411302318100_B17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"issue":"9","key":"2020032411302318100_B18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/nprot.2013.099","article-title":"Count-based differential expression analysis of RNA sequencing data using R and Bioconductor","volume":"8","author":"Anders","year":"2013","journal-title":"Nat Protoc"},{"key":"2020032411302318100_B19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"7","key":"2020032411302318100_B20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat Methods"},{"key":"2020032411302318100_B21","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2020032411302318100_B22","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1093\/nar\/gkq149","article-title":"Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data","volume":"38","author":"Essaghir","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2020032411302318100_B23","doi-asserted-by":"crossref","first-page":"e1003198","DOI":"10.1371\/journal.pcbi.1003198","article-title":"Genome-wide signatures of transcription factor activity: connecting transcription factors, disease, and small molecules","volume":"9","author":"Chen","year":"2013","journal-title":"PLOS Comput Biol"},{"issue":"6","key":"2020032411302318100_B24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"1","key":"2020032411302318100_B25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1214\/07-AOAS104","article-title":"Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis","volume":"1","author":"Newton","year":"2007","journal-title":"Ann Appl Stat"},{"issue":"1","key":"2020032411302318100_B26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-2105-10-234","article-title":"CLEAN: CLustering Enrichment ANalysis","volume":"10","author":"Freudenberg","year":"2009","journal-title":"BMC Bioinformatics"},{"issue":"43","key":"2020032411302318100_B27","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2020032411302318100_B28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41409-018-0159-8","article-title":"High-dose carboplatin\/etoposide\/melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma","volume":"53","author":"Jodele","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2020032411302318100_B29","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.bbmt.2018.12.840","article-title":"Thrombotic microangiopathy following pediatric autologous hematopoietic cell transplantation: a report of significant end-organ dysfunction in eculizumab-treated survivors","volume":"25","author":"Schoettler","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020032411302318100_B30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr"},{"issue":"3","key":"2020032411302318100_B31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"2020032411302318100_B32","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","article-title":"Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD","volume":"2","author":"Wall","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"2020032411302318100_B33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41409-018-0293-3","article-title":"High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease","volume":"54","author":"Kraft","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2020032411302318100_B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2020032411302318100_B35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.11.011","article-title":"Complement in basic processes of the cell","volume":"84","author":"Jim\u00e9nez-Reinoso","year":"2017","journal-title":"Mol Immunol"},{"issue":"6","key":"2020032411302318100_B36","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.160.6.2619","article-title":"Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice","volume":"160","author":"Fischer","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"2020032411302318100_B37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"2020032411302318100_B38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2020032411302318100_B39","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1073\/pnas.1821367117","article-title":"Population-based RNA profiling in Add Health finds social disparities in inflammatory and antiviral gene regulation to emerge by young adulthood","volume":"117","author":"Cole","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2020032411302318100_B40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.RV17026","article-title":"Pathogenesis of atypical hemolytic uremic syndrome","volume":"26","author":"Yoshida","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"2020032411302318100_B41","first-page":"1259","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume-title":"Blood","author":"Gloude","year":"2017"},{"issue":"73","key":"2020032411302318100_B42","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"issue":"3","key":"2020032411302318100_B43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/14397595.2013.874761","article-title":"A case of Degos disease: demonstration of C5b-9-mediated vascular injury","volume":"25","author":"Umemura","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2020032411302318100_B44","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1542\/peds.2016-4206","article-title":"Pediatric malignant atrophic papulosis","volume":"141","author":"Huang","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"2020032411302318100_B45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: a C5b-9\/interferon-\u03b1-mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020032411302318100_B46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1750-1172-8-185","article-title":"The effects of eculizumab on the pathology of malignant atrophic papulosis","volume":"8","author":"Magro","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2020032411302318100_B47","unstructured":"Rice AS , ZedekD. Malignant Atrophic Papulosis (Degos Disease). StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 18 November 2019."},{"key":"2020032411302318100_B48","first-page":"18","article-title":"The natural history of BK polyomavirus and the host immune response after stem cell transplantation","author":"Laskin","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2020032411302318100_B49","doi-asserted-by":"crossref","first-page":"e1007505","DOI":"10.1371\/journal.ppat.1007505","article-title":"Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence","volume":"15","author":"An","year":"2019","journal-title":"PLoS Pathog"},{"key":"2020032411302318100_B50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.micpath.2019.02.015","article-title":"Increasing of the interferon-\u03b3 gene expression during polyomavirus BK infection in kidney transplant patients","volume":"129","author":"Zareei","year":"2019","journal-title":"Microb Pathog"},{"issue":"5","key":"2020032411302318100_B51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ckj\/sfw143","article-title":"Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab","volume":"10","author":"Allinovi","year":"2017","journal-title":"Clin Kidney J"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/6\/1166\/1720048\/advancesadv2020001515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/6\/1166\/1720048\/advancesadv2020001515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T16:52:52Z","timestamp":1722617572000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/6\/1166\/452757\/Interferoncomplement-loop-in-transplantassociated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001515","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]}}}